HER3 amplification is a very rare gene alteration found in 0.2% of pancreatic cancers, according to the Center for Cancer Genomics and Advanced Therapeutics (C‐CAT) database, which consists of data from cancer gene panel tests covered by health insurance in Japan [37]. The gene discussed is ERBB3; the disease is cancer.